The DOI matches its Crossref record; 114 of the 116 references it cites were found in a registry or an index.
Molecular Markers of Early Pancreatic Cancer
Abstract
Pancreatic cancer is a deadly disease and the fourth most common cause of cancer death in the United States. Since chemotherapy and radiotherapy have thus far largely failed to significantly improve the survival of patients with pancreatic ductal adenocarcinoma, there is considerable interest in identifying better diagnostic markers of pancreatic neoplasia. Not only could better markers improve the early diagnosis of pancreatic cancer and allow more patients to undergo curative surgical resection, but also could potentially be used for patients at high risk of developing pancreatic cancer to identify precancerous lesions while they are amenable to cure. A wealth of information has recently become available about gene expression, DNA methylation, and proteomics alterations that occur in pancreatic cancers creating hope that better diagnostic markers of pancreatic cancer will be soon forthcoming.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“only 65% of patients with resectable pancreatic ductal adenocarcinoma have elevated serum levels of CA19–9,77”
From Early detection of pancreatic cancer (2020) · cites this paper as [77]
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Colorectal carcinoma antigens detected by hybridoma antibodies
Koprowski, H., Steplewski, Z., Mitchell, K. F., Herlyn, M., Herlyn, D., & Fuhrer, P. (1979) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01542654 · Cited by 1,360
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S. M., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,180
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132
Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126675.59108.80 · Cited by 1,091
Self-citationHereditary Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Perrault, J., Whitcomb, D. C., & International Hereditary Pancreatitis Study Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.442 · Cited by 988
Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients
Yeo, C. J., Cameron, J. L., Lillemoe, K. D., Sitzmann, J. V., Hruban, R. H., Goodman, S. N., Dooley, W. C., Coleman, J., & Pitt, H. A. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00011 · Cited by 945
Flagged first, then by citations
2 of the 116 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- 10.1023/A:1008386130283 · DOI
- 10.1016/S0889-8588(01)00007-7 · DOI
- 10.7326/0003-4819-131-4-199908170-00003 · DOI · Paper page
- 10.4161/cbt.206 · DOI
Cited by
Sorted by citations
Items 201–214 of 214
Assessment of the presence of pancreatic intraepithelial neoplasia in various diseases of this organ
Zińczuk, J., Zaręba, K. P., Duchnowska, E., Guzińska-Ustymowicz, K., Kędra, B., Kemonä, A., & Pryczynicz, A. (2017) · Progress in Health Sciences · doi:10.5604/01.3001.0010.5718
Leung, J. W. (2015) · Journal of Interventional Gastroenterology · doi:10.7178/jig.180
Pancreatic cancer: Removing extracellular matrix barrier in delivery
Jain, S., Raza, K., Agrawal, A. K., & Vaidya, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817846-1.00021-7
Proteomanalyse : Basis für individualisierte Pankreaskarzinomtherapie?
Löhr, M. J., Faissner, R., Findeisen, P., & Neumaier, M. (2006) · Der Internist
Chronic Pancreatitis and Pancreatic Cancer
Kong, X., & Xie, K. (2017) · Springer eBooks · doi:10.1007/978-981-10-4515-8_12 · Cited by 1
Rosette nanotube-mediated delivery of RNA
Reyes, G. K. L. D. (2018) · doi:10.17760/d20316332
The Tumor and Its Microenvironment as Complementary Sources of Cancer Biomarkers
Roy, R., Man, E., Aldakhlallah, R., Rashes, E. R., & Moses, M. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_22
Role of Circulating MicroRNAs in Prognosis and Diagnosis of Cancers
Prasad, D., Vurla, P., Sushma, P. S., Babu, M. S., Aruna, P., & Khan, I. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-9186-7_7
Combating Cancer Using Nanomaterials: Development and Challenges
Husain, S., Shaw, S., Bose, S. K., & Nayak, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_45
Introduction to colon and pancreatic cancers
Shah, S., Haider, S., Khan, O. S., Rashid, M. U., Alomari, M., Rahman, A. U., & Ahmad, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24742-2.00019-8
Molecular mechanisms of drug resistance, invasion and metastasis in pancreatic carcinoma
Walsh, N. (2008) · Arrow@dit (Dublin Institute of Technology)
Pietrasz, D. (2021) · theses.fr (ABES) · doi:10.70675/c472e16fzf3fdz431dz883cz48ea933497f9
Hekimsoy, S., Soylu, A., Bayram, M., Uzun, H., & Tabak, Ö. (2026) · Medicina · doi:10.3390/medicina62050982
Early detection of pancreatic cancer by evaluating combined serum biomarker: The key questions
Noor, F., Rehman, M. S. U., Ambreen, U. E., & Sattar, T. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i7.115270
Metadata
- Authors
- Goggins, M.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Goggins, Michael
- ORCID
- Goggins, Michael
- Venue
- Journal of Clinical Oncology
- Published
- 2005-07-10
- Volume
- 23
- Issue
- 20
- Pages
- 4524-4531
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2127793931
- Cited by
- 214
- References
- 116
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 6 · 2023: 5 · 2022: 11 · 2021: 9 · 2020: 11 · 2019: 10 · 2018: 11 · 2017: 13 · 2016: 9 · 2015: 9 · 2014: 13 · 2013: 15 · 2012: 13
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- pancreatic cancer, early diagnosis, diagnostic biomarkers, pancreatic ductal adenocarcinoma, gene expression changes, DNA methylation, proteomics, precancerous lesions, high-risk patients
- MeSH terms
- Genetic Markers, Humans, Pancreatic Neoplasms, Biomarkers, Tumor, Carcinoma, Pancreatic Ductal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
